European commercialization introduces an additional aflibercept biosimilar option for major retinal indications, potentially ...

Tavo Biotherapeutics Secures $17M to advance glaucoma and retinal disease therapies through clinical development and growth.

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

Tavo Biotherapeutics today announced the successful closing of a $17 million Series A financing led by Pureos Bioventures with participation by Polaris Partners and continued support from existing ...

In addition to Ocular leadership, event to feature prominent retinal disease experts Dr. Arshad M. Khanani, MD, MA, FASRS; Dr. Lejla Vajzovic, MD, FASRS; and Dr. Darius M. Moshfeghi, MD  Company to ...

Opus Genetics, Inc. (Nasdaq: IRD) ('Opus Genetics” or the 'Company”), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with ...

Belite Bio, Inc (NASDAQ: BLTE) ('Belite Bio®” or the 'Company”), a clinical-stage drug development company focused on ...

An AI-assisted model based on 71 different blood proteins could help doctors better predict retinal degeneration in diabetic ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that the Company will present on its innovative ...

Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative ...

Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...

Florida is scheduled to execute Andrew Lukehart for the 1996 murder of a 5-month-old baby. Lukehart was convicted of striking ...